Hseu Anne F, Spencer Grant, Woodnorth Geralyn, Kagan Sydney, Kawai Kosuke, Nuss Roger C
Department of Otolaryngology and Communication Enhancement, Boston Children's Hospital, Boston, Massachusetts; Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts.
Department of Otolaryngology and Communication Enhancement, Boston Children's Hospital, Boston, Massachusetts.
J Voice. 2023 May;37(3):410-414. doi: 10.1016/j.jvoice.2021.01.008. Epub 2021 Feb 23.
The most common etiologies of dysphonia in the pediatric population are vocal fold nodules and muscle tension dysphonia. Vocal therapy is the first line treatment for these disorders in children. Despite this, not all children undergo therapy. The goal of this study is to examine how factors such as patient demographics and parental perceptions differ between children that choose to undergo or not to undergo voice therapy.
A retrospective review was conducted of all pediatric patients seen at a tertiary voice clinic between January 2014 and December 2017. Patients were included if diagnosed with vocal fold nodules and/or muscle tension dysphonia. Patients were divided into groups of children that received voice therapy at our institution and those that did not. Data include demographics, Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V) scores and pediatric Voice Handicap Index (pVHI) scores. Distance to therapy site was approximated using patient zip codes.
Three hundred and forty-six children were included, 224 (65%) boys and 122 (35%) girls. In the 2 years following initial diagnosis, 74 (21%) children participated in voice therapy at our institution. Patients who underwent voice therapy were older than those who did not (mean age: 9.1 [SD 3.5] vs 7.6 [SD 3.8] years; P = 0.004). Patients who received voice therapy were more likely to live closer to the therapy site (mean distance: 15.5 [SD 13.0] vs 24.3 [SD 23.9] miles; P< 0.001). Likelihood of receiving voice therapy did not differ by gender or health insurance status (private vs public). Patients who underwent voice therapy had significantly greater CAPE-V Overall Severity scores than those who did not (mean score: 44.6 [SD 19.4] vs 37.4 [SD 18.0]; P = 0.003). Higher CAPE-V Strain scores were associated with increased likelihood of voice therapy. pVHI scores did not differ between the two groups.
Older age, shorter distance to therapy site, and increased CAPE-V Overall Severity and Strain scores were associated with higher likelihood of receiving voice therapy. Gender, insurance status, and pVHI scores did not affect likelihood of receiving voice therapy. Patients may primarily consider ease of access and necessity of treatment when considering voice therapy.
儿童嗓音障碍最常见的病因是声带小结和肌张力性发声障碍。嗓音治疗是儿童这些疾病的一线治疗方法。尽管如此,并非所有儿童都接受治疗。本研究的目的是探讨选择接受或不接受嗓音治疗的儿童在患者人口统计学特征和家长认知等因素上有何差异。
对2014年1月至2017年12月在一家三级嗓音诊所就诊的所有儿科患者进行回顾性研究。如果诊断为声带小结和/或肌张力性发声障碍则纳入研究。患者分为在本机构接受嗓音治疗的儿童组和未接受治疗的儿童组。数据包括人口统计学特征、嗓音听觉感知综合评估(CAPE-V)评分和儿童嗓音障碍指数(pVHI)评分。使用患者邮政编码估算到治疗地点的距离。
共纳入346名儿童,其中224名(65%)为男孩,122名(35%)为女孩。在初次诊断后的2年里,74名(21%)儿童在本机构接受了嗓音治疗。接受嗓音治疗的患者比未接受治疗的患者年龄大(平均年龄:9.1[标准差3.5]岁对7.6[标准差3.8]岁;P = 0.004)。接受嗓音治疗的患者住得离治疗地点更近的可能性更大(平均距离:15.5[标准差13.0]英里对24.3[标准差23.9]英里;P<0.001)。接受嗓音治疗的可能性在性别或健康保险状况(私人保险与公共保险)方面没有差异。接受嗓音治疗的患者的CAPE-V总体严重程度评分显著高于未接受治疗的患者(平均评分:44.6[标准差19.4]对37.4[标准差18.0];P = 0.003)。CAPE-V紧张度评分越高,接受嗓音治疗的可能性越大。两组之间的pVHI评分没有差异。
年龄较大、到治疗地点的距离较短以及CAPE-V总体严重程度和紧张度评分增加与接受嗓音治疗的可能性较高有关。性别、保险状况和pVHI评分不影响接受嗓音治疗的可能性。患者在考虑嗓音治疗时可能主要考虑就医便利性和治疗必要性。